New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
08:50 EDTLMNX, LHLabCorp announces availability of xTAG CYP2D6 genotype assay
LabCorp (LH) announced the availability of the xTAG CYP2D6 Kit v3 from Luminex (LMNX). The xTAG CYP2D6 Kit v3 is an FDA cleared qualitative genotyping assay that aids clinicians in determining strategies for therapeutics metabolized by the CYP2D6 gene product.
News For LH;LMNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2015
15:57 EDTLHLabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
September 30, 2015
08:46 EDTLHLabCorp's Bode Cellmark enters service pact with DANY
Subscribe for More Information
September 25, 2015
12:53 EDTLMNXLuminex management to meet with William Blair
Meeting to be held in Chicago on September 30 hosted by William Blair.
September 20, 2015
13:59 EDTLHOPKO Health may face challenge with Bio-Reference acquisition, Barron's says
OPKO Health (OPK) "could face a big challenge" with its acquisition of Bio-Reference, Barron's contends in its 'Follow Up' column. Barron's conducted recent interviews with former Bio-Reference salespeople, who allege that the company pushed expensive, unnecessary tests on patients, resulting in pushback from health insurers. Additionally, the former employees claim the company was willing to waive patient co-payments in order to better compete with LabCorp (LH) and Quest Diagnostics (DX), says Barron's. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use